JB Chemicals gets USFDA nod to market generic medication

JB Chemicals & Pharmaceuticals on Wednesday received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market. The company's product is the generic version of Pfizer's Sinequan capsules which are indicated for the treatment of anxiety, depression, and other target symptoms of psychoneurosis.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Uyepsrl
via IFTTT